PT - JOURNAL ARTICLE AU - Rannikmäe, Kristiina AU - Rawlik, Konrad AU - Ferguson, Amy C AU - Avramidis, Nikos AU - Jiang, Muchen AU - Pirastu, Nicola AU - Shen, Xia AU - Davidson, Emma AU - Woodfield, Rebecca AU - Malik, Rainer AU - Dichgans, Martin AU - Tenesa, Albert AU - Sudlow, Cathie TI - Physician-confirmed and administrative definitions of stroke in UK Biobank reflect the same underlying genetic trait AID - 10.1101/2021.09.30.21264348 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.30.21264348 4099 - http://medrxiv.org/content/early/2021/10/01/2021.09.30.21264348.short 4100 - http://medrxiv.org/content/early/2021/10/01/2021.09.30.21264348.full AB - Background Stroke in UK Biobank (UKB) is ascertained via linkages to coded administrative datasets and self-report. We studied the accuracy of these codes using genetic validation.Methods We compiled stroke-specific and broad cerebrovascular disease (CVD) code lists (Read V2/V3, ICD-9/-10) for medical settings (hospital, death record, primary care) and self-report. Among 408,210 UKB participants we identified all with a relevant code, creating 12 stroke definitions based on the code type and source. We performed genome-wide association studies (GWASs) for each definition, comparing summary results against the largest published stroke GWAS (MEGASTROKE), assessing genetic correlations, and replicating 32 stroke-associated loci.Results Stroke case numbers identified varied widely from 3,976 (primary care stroke-specific codes) to 19,449 (all codes, all sources). All 12 UKB stroke definitions were significantly correlated with the MEGASTROKE summary GWAS results (rg 0.81-1) and each other (rg 0.4-1). However, Bonferroni-corrected confidence intervals were wide, suggesting limited precision of some results. Six previously reported stroke-associated loci were replicated using ≥1 UKB stroke definitions.Conclusions Stroke case numbers in UKB depend on the code source and type used, with a 5-fold difference in the maximum case-sample size. All stroke definitions are significantly genetically correlated with the largest stroke GWAS to date.Competing Interest StatementThe authors have declared no competing interest.Funding StatementK Rannikmae is funded by Health Data Research UK Rutherford fellowship MR/S004130/1. AF is funded by BHF award RE/18/5/34216 and MR/S004130/1. This work was supported by the Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund. AT is funded by HDR-UK awards HDR-9004 and HDR-9003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank project 2532All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analyzed for this study is available from the UK Biobank and the MEGASTROKE consortium website upon request (https://www.megastroke.org/).